TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.94 Cr | ₹-0.15 Cr | ₹-0.52 Cr | ₹-1.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TRIDENT LIFELINE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.94 Cr |
| Mar2024 | ₹-0.15 Cr |
| Mar2023 | ₹-0.52 Cr |
| Mar2022 | ₹-1.04 Cr |
How is Deferred Tax Assets / Liabilities of TRIDENT LIFELINE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.94 Cr | Negative | |
| Mar2024 | ₹-0.15 Cr | Negative | |
| Mar2023 | ₹-0.52 Cr | Negative | |
| Mar2022 | ₹-1.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹313.8 Cr | 1.5% | 6.4% | -6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 1.5% |
6.4% |
-6.6% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses